tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

PharmaCyte Biotech Video Documentary Released

PharmaCyte Biotech Video Documentary Released

SILVER SPRING, MD, June 1, 2015  — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has launched a new corporate video. In the video viewers will learn the PharmaCyte Biotech story first hand through interviews and footage shot in Singapore, Thailand, Sweden and Arizona.  

Click to View the Company’s Corporate Video

The video documents PharmaCyte Biotech’s live-cell encapsulation technology, Cell-in-a-Box®, and how it is produced in Singapore and Thailand. Viewers will learn of the technology’s advantages over other encapsulation technologies, improvements that have been made to the technology since the first clinical trials and how PharmaCyte Biotech will use Cell-in-a-Box® in treatments for diabetes, cancer and symptoms related to solid cancerous tumors. PharmaCyte Biotech’s cancer and diabetes portfolios will also be featured, complete with preclinical and clinical data highlighting the technology’s performance.

Kenneth L. Waggoner, Chief Executive Officer of PharmaCyte Biotech, said, “We are excited to present this video. This video will take viewers right into each of the facilities that are and will be so instrumental in our success in both cancer and diabetes. The rich footage and stellar interviews highlight what we feel is a formidable story in the biotech industry.

“We have so many people to thank for their time and participation in getting this documentary-like video produced. First, we’d like to thank our partner, Austrianova, and Prof. Walter H. Gunzburg, and Dr. Brian Salmons for letting us spend time with them at their facilities in Singapore and Thailand. We are grateful to Dr. Matthias Löhr for taking time out of his extremely busy schedule to host us at the Karolinska Institute in Stockholm, Sweden. Finally, we’d like to extend many thanks to the entire staff at Translational Drug Development (TD2) and Dr. Stephen Gately, the Chief Executive Officer of TD2, for letting us spend a couple of days at TD2’s facility on the Mayo Clinic campus in Scottsdale, Arizona.”